Back to search

Peptide record

TPDB03406

Antibacterial Anticancer Toxicity standard
28 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB03406
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 Peptipedia
standard
No
A 28-aa standard natural multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from AntiBP3 and Peptipedia, with an available 3D structural model.
Sequence
LRPLLRPLLRPLLRPLLRPLLRPLLRPL
Physicochemical Analysis
C161H289N49O29
ANDCEQGHIKMFSTWYV
L
3375.38
13.18
7
0
14
+7
0.98
0.375
195.00
Mammalian: 5.5 hour Yeast: 3 min E.coli: 2 min
0
0.00
0
Residue Composition
number
0
A
7
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
0
I
14
L
0
K
0
M
0
F
7
P
0
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 7 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 0 L: 14 K: 0 M: 0 F: 0 P: 7 S: 0 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
28
C161H289N49O29
3375.38
13.18
+7
0.98
0.375
Evidence Records 3 records
Evidence 1 Activity

Activity

10% Hemolysis
Toxicity
64 µM
Hemolytic Cytotoxic
10% Hemolysis | 64 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Antimicrobial peptides with high proteolytic resistance for combating gram-negative bacteria. | J Med Chem | 2019
Evidence 2 Activity

Activity

IC50
Toxicity
19.21 µM
Cytotoxic
IC50 | 19.21 | µM | target cell: Human embryonic kidney HEK293T cells

Target

Human embryonic kidney HEK293T cells

Source & Reference

NA
DBAASP
Antimicrobial peptides with high proteolytic resistance for combating gram-negative bacteria. | J Med Chem | 2019
Evidence 3 Activity

Activity

IC50
Toxicity
10.65 µM
Cytotoxic
IC50 | 10.65 | µM | target cell: Intestinal Porcine Epithelial Cells IPEC-J2

Target

Intestinal Porcine Epithelial Cells IPEC-J2

Source & Reference

NA
DBAASP
Antimicrobial peptides with high proteolytic resistance for combating gram-negative bacteria. | J Med Chem | 2019